Patient characteristics in children treated with IST or BMT for severe aplastic anemia
. | All patients . | Patients with SAA . | Patients with vSAA . | P . |
|---|---|---|---|---|
| No. patients | 213 | 76 | 137 | |
| Age, median, y (range) | 8.9 (0.91-16.95) | 10.43 (1.42-16.93) | 8.06 (0.91-16.95) | .010* |
| Sex, no. (%) | .146† | |||
| Male | 125 (59) | 50 (66) | 75 (55) | |
| Female | 88 (41) | 26 (34) | 62 (45) | |
| Etiology, no. (%) | .874‡ | |||
| Idiopathic | 1.71 (80) | 63 (83) | 108 (79) | |
| Toxic | 9 (4) | 3 (4) | 6 (4) | |
| After hepatitis | 18 (9) | 6 (8) | 12 (9) | |
| Postviral infection | 15 (7) | 4 (5) | 11 (8) | |
| Interval between diagnosis and treatment, median, mo (range) | 0.90 (0.03-8.94) | 1.26 (0.20-8.94) | 0.92 (0.03-8.21) | .002§ |
. | All patients . | Patients with SAA . | Patients with vSAA . | P . |
|---|---|---|---|---|
| No. patients | 213 | 76 | 137 | |
| Age, median, y (range) | 8.9 (0.91-16.95) | 10.43 (1.42-16.93) | 8.06 (0.91-16.95) | .010* |
| Sex, no. (%) | .146† | |||
| Male | 125 (59) | 50 (66) | 75 (55) | |
| Female | 88 (41) | 26 (34) | 62 (45) | |
| Etiology, no. (%) | .874‡ | |||
| Idiopathic | 1.71 (80) | 63 (83) | 108 (79) | |
| Toxic | 9 (4) | 3 (4) | 6 (4) | |
| After hepatitis | 18 (9) | 6 (8) | 12 (9) | |
| Postviral infection | 15 (7) | 4 (5) | 11 (8) | |
| Interval between diagnosis and treatment, median, mo (range) | 0.90 (0.03-8.94) | 1.26 (0.20-8.94) | 0.92 (0.03-8.21) | .002§ |